← Back
$AXSM All transactions

Axsome Therapeutics, Inc.

M 10b5-1 Plan

$ Value

$85K

Shares

10,558

Price

$8

Filed

Dec 4

Insider

Name

TABUTEAU HERRIOT

Title

Chief Executive Officer

CIK

0001219927

Roles

Director Officer 10% Owner

Transaction Details

Transaction Date

2025-12-04

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

17,787

Footnotes

Necessary exercise of stock options set to expire due to attainment of the 10-year expiration date of such options. | Such transaction was pursuant to a pre-approved 10b5-1 plan. | Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options. | Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $141.79 and $149.23. | Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $142.66 and $148.39. | Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $146.77 and $149.41. | Such shares are held by an entity, of which the reporting person has voting and dispositive power, and therefore, the reporting person is deemed to be the indirect beneficial owner of such shares.

Filing Info

Accession No.

0001193125-25-308354

Form Type

4

Issuer CIK

0001579428

TABUTEAU HERRIOT's History

Date Ticker Type Value
2026-04-21 AXSM A $0
2026-02-26 AXSM A $0
2026-02-02 AXSM M $260K
2026-02-02 AXSM $6.0M
2026-02-02 AXSM M $0
2026-01-07 AXSM M $251K
2026-01-07 AXSM $5.3M
2026-01-07 AXSM M $0
2026-01-06 AXSM M $236K
2026-01-06 AXSM $5.1M

Other Insiders at AXSM (90d)

Insider Bought Sold Last
TABUTEAU HERRIOT
Chief Executive Officer
$6.0M 2026-04-21
Coleman Mark $4.0M 2026-02-26
Pizzie Nick
Chief Financial Officer
2026-04-21
Jacobson Mark L.
Chief Operating Officer
$5.7M 2026-04-21
Murdock Hunter R.
General Counsel
2026-04-21
Maizel Ari
Chief Commercial Officer
$1.4M 2026-04-22